References
- Armstrong J., Blackwell G. J., Flower R. J., McGiff J. C., Mullane K. M., Vane J. R. Genetic hypertension in rats is accompanied by a defect in renal prostaglandin catabolism. Nature 1976; 260: 582
- Carretero O., Polonski C., Hampton A., Scicli A. G. Urinary kallikrein, plasma renin and aldosterone in New Zealand genetically hypertensive (GH) rats. Clin Exp Pharmacol Physiol. Suppl 1976; 3: 55
- Clark D. W. J., Phelan E. L. The role of the sympathetic nervous system in the pathogenesis of genetic hypertension (GH) in rats: a brief review. Clin Exp Pharmacol Physiol. Suppl 1976; 3: 65
- Crofton J., Share L., Shade R. E., Lee-Kwon W. J., Manning M., Sawyer W. H. The importance of vasopressin in the development and maintenance of DOC-salt hypertension in the rat. Hypertension 1979; 1: 31
- Crofton J., Share L, Shade R. E., Allen C., Tarnowski D. Vasopressin in the rat with spontaneous hypertension. Am J Physiol 1978; 235: H361
- Crofton J., Share L., Wang B. C., Shade R. E. Pressor responsiveness to vasopressin in the rat with DOC-salt hypertension. Hypertension 1980; 2: 424
- Gresson C., Bird D. L., Simpson F. O. Plasma volume, extracellular fluid volume and exchangeable sodium concentrations in the New Zealand strain of genetically hypertensive rat. Clin Sci 1973; 44: 349
- Hoffman W., Phillips M. I., Schmid P. G. Central angiotensin II-induced responses in spontaneously hypertensive rats. Am J Physiol 1977; 232: H426
- Khokhar A., Slater J. D. H. Increased renal excretion of arginine-vasopressin during mild hydropenia in young men with mild essential benign hypertension. Clin Sci Mol Med 1976; 51: 691s
- McKenzie J., Phelan E. L. Plasma and renal renin in the New Zealand strain of genetic hypertensive and random-bred control rats. Proc Univ Otago Med Schl 1969; 47: 23
- Möhring J. Neurohypophyseal vasopressor principle, vasopressor hormone as well as antidiuretic hormone?. Klin Wochenschr 1978; 56(Suppl 1)71
- Möhring J., Möhring B., Petri M., Haack D. Vasopressor role of ADH in the pathogenesis of malignant DOC hypertension. Am J Physiol 1977; 232: F260
- Möhring J., Möhring B., Petri M., Haack D. Plasma vasopressin concentrations and effects of vasopressin antiserum on blood pressure in rats with malignant two-kidney Goldblatt hypertension. Circ Res 1978; 42: 17
- Padfield P., Brown J. J., Lever A. F., Morton J. J., Robertson J. I. S. Changes of vasopressin in hypertension: cause or effect?. The Lancet 1976; 1: 1255
- Phelan E., Clark D. W. J., Jones D. R. Cardiac ouput and regional vascular resistance in the hindlimbs and tails of genetically hypertensive (GH) rats, Clin Exp Pharmacol Physiol. Suppl 1976; 3: 141
- Phelan E., Eryetishir I., Smirk F. H. Observations on the responses of rats with spontaneous hypertension and control rats to pressor drugs and to hexamethonium. Circ Res 1962; 10: 817